Skip to main content

Diabetes and Metabolism

The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.  

The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).

Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR. 

The main lines of research are:

  • Complications of diabetes (in particular diabetic retinopathy)
  • Obesity and its co-morbidities
  • Type 2 diabetes and cognitive impairment
  • Thyroid diseases
  • Hospital Nutrition. 

Team

Laura Hidalgo Corbacho

Laura Hidalgo Corbacho

Predoctoral researcher
Diabetes and Metabolism
Read more
Lidia Fuertes Rioja

Lidia Fuertes Rioja

Research technician
Diabetes and Metabolism
Read more
Marc Bernaus Esqué

Marc Bernaus Esqué

Postdoctoral researcher
Diabetes and Metabolism
Read more
Marcos Dos Santos Gil

Marcos Dos Santos Gil

Research technician
Diabetes and Metabolism
Read more
Maria Jose Canz Marquez

Maria Jose Canz Marquez

Research technician
Diabetes and Metabolism
Read more
Olivia Casbas Recuenco

Olivia Casbas Recuenco

Predoctoral researcher
Diabetes and Metabolism
Read more
Laura Hidalgo Corbacho

Laura Hidalgo Corbacho

Predoctoral researcher
Diabetes and Metabolism
Read more
Lidia Fuertes Rioja

Lidia Fuertes Rioja

Research technician
Diabetes and Metabolism
Read more
Marc Bernaus Esqué

Marc Bernaus Esqué

Postdoctoral researcher
Diabetes and Metabolism
Read more
Marcos Dos Santos Gil

Marcos Dos Santos Gil

Research technician
Diabetes and Metabolism
Read more
Maria Jose Canz Marquez

Maria Jose Canz Marquez

Research technician
Diabetes and Metabolism
Read more
Olivia Casbas Recuenco

Olivia Casbas Recuenco

Predoctoral researcher
Diabetes and Metabolism
Read more

Projects

Clinical development of RetSit@, a first-in-class neuroprotective drug to treat Early Stages of Diabetic Retinopathy

IP: Rafael Simó Canonge
Collaborators: Olga Simó Servat, Marta Garrido Marin, Miguel Angel Zapata Victori
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 602031
Reference: CPP2023-010602
Duration: 01/10/2024 - 30/09/2027

Ministerio de Ciencia

Utilidad del TAC abdominal e inteligencia artificial para la evaluación de la composición corporal y condición metabólica en sujetos con obesidad: estudio FLASH

IP: Andreea Ciudin Mihai
Collaborators: Manuel Escobar Amores, Nuria Roson Gradaille, Fiorella Ximena Palmas Candia, Aitor Rodriguez Martinez, Marta Comas Martinez, Enzamaría Fidilio Meli
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 431460
Reference: CPP2023-010524
Duration: 01/11/2024 - 30/10/2027

Ministerio de Ciencia

Plataforma de soporte para la Investigación Clínica

IP: Inmaculada Fuentes Camps
Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Ariadna Martín Balcells, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero
Funding agency: Instituto de Salud Carlos III
Funding: 274920
Reference: PT23/00062
Duration: 01/01/2024 - 31/12/2026

Retinal and cognitive dysfunction in type 2 diabetes

IP: Rafael Simó Canonge
Collaborators: Maria Llorian Salvador, Miriam Izquierdo Sans
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 152348.46
Reference: 2022 BP 00067
Duration: 01/04/2024 - 31/03/2027

Blog

News

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.